OPKO Health
OPK
$1.32
Share price
1.54%
Change (1 day)
-16.46%
Change (1 year)
Categories
OPKO Health (OPK) - P/B ratio
P/B ratio as of May 2024 : 0.6522
According to OPKO Health
's latest financial reports the company has a price-to-book ratio of 0.6522.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
OPKO Health - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.8403 | 35.86% |
| 2022-12-31 | 0.6185 | -68.2% |
| 2021-12-31 | 1.94 | 22.84% |
| 2020-12-31 | 1.58 | 159.64% |
| 2019-12-31 | 0.6098 | -38.11% |
| 2018-12-31 | 0.9852 | -33.73% |
| 2017-12-31 | 1.49 | -40.02% |
| 2016-12-31 | 2.48 | -10.41% |
| 2015-12-31 | 2.77 | -46.44% |
| 2014-12-31 | 5.17 | 29.52% |
| 2013-12-31 | 3.99 | -44.83% |
| 2012-12-31 | 7.23 | -5.82% |
| 2011-12-31 | 7.68 | -81.12% |
| 2010-12-31 | 40.7 | 176.69% |
| 2009-12-31 | 14.7 | -98.36% |
| 2008-12-31 | 897 | 2861.26% |
| 2007-12-31 | 30.3 | -95.6% |
| 2006-12-31 | 688 | 86593.57% |
| 2005-12-31 | 0.7933 | 41.35% |
| 2004-12-31 | 0.5612 | -59.04% |
| 2003-12-31 | 1.37 | 288.78% |
| 2002-12-31 | 0.3524 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.30 | 713.03% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.70 | 620.40% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | 3.95 | 505.86% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 5.40 | 728.45% | 🇺🇸 USA |
 LabCorp LH | 2.25 | 245.40% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -87.2 | -13,474.86% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 2.29 | 250.59% | 🇮🇱 Israel |
 Ardelyx ARDX | 10.9 | 1,575.22% | 🇺🇸 USA |